Suchergebnisse - "Zamora, Alberto"

PubPharm (56)

1

Documento de consenso de la Sociedad Española de Obstetricia y Ginecologia (SEGO) y el Comité Español Interdisciplinario para la Prevención Vascular (CEIPV). Ventana de oportunidad : prevención del riesgo vascular en la mujer. Resultados adversos del embarazo y riesgo de enfermedad vascular.

enthalten in: Revista espanola de salud publica | 2023

von Goya, M. | Miserachs, M. | Suy Franch, A. | +24

2

Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in Spain

enthalten in: Advances in therapy | 2023

von Cosin-Sales, J. | Sidelnikov, E. | Villamayor, S. | +3

3

Intraputaminal Gene Delivery in Two Patients with Aromatic L-Amino Acid Decarboxylase Deficiency

enthalten in: Movement disorders clinical practice | 2023

von François-Heude, M. | Poulen, G. | Flamand Roze, E. | +25

4

Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention

enthalten in: Nefrologia | 2023

von Brotons, C. | Camafort, M. | Castellanos, M. | +19

5

Correction : Evaluation Criteria for Weight Management Apps: Validation Using a Modified Delphi Process

enthalten in: JMIR mHealth and uHealth | 2023

von Robles, N. | Puigdomènech Puig, E. | Gómez-Calderón, C. | +7

ErratumFor: JMIR Mhealth Uhealth. 2020 Jul 22;8(7):e16899. - PMID 32706689

6

Correction : Assessment of the Efficacy, Safety, and Effectiveness of Weight Control and Obesity Management Mobile Health Interventions: Systematic Review

enthalten in: JMIR mHealth and uHealth | 2023

von Puigdomenech Puig, E. | Robles, N. | Saigí-Rubió, F. | +7

ErratumFor: JMIR Mhealth Uhealth. 2019 Oct 25;7(10):e12612. - PMID 31654566

7

Women with familial hypercholesterolemia phenotype are undertreated and poorly controlled compared to men

enthalten in: Scientific reports | 2023

von Zamora, A. | Ramos, R. | Comas-Cufi, M. | +12

8

Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in Spain

enthalten in: Advances in therapy | 2022

von Cosin-Sales, J. | Sidelnikov, E. | Villamayor, S. | +3

9

Identification of secondary prevention patients eligible for PCSK9 inhibitors therapy according to the routine clinical practice in Spain

enthalten in: ResearchSquare.com | 2022

von Cosin-Sales, J. | Sidelnikov, E. | Villamayor, S. | +3

10

Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention

enthalten in: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis | 2022

von Brotons, C. | Camafort, M. | Castellanos, M. | +19

1
2
3
4
5
6
Nächster »
[6]